Azithromycin works by blocking bacteria's ability to make essential proteins, effectively starving them. Its exceptional tissue penetration and long-lasting effects allow for shorter treatment courses while maintaining effectiveness against both typical and atypical respiratory pathogens.
Azithromycin works through a sophisticated mechanism that makes it uniquely effective against many bacteria, especially those that cause respiratory and atypical infections in children. Unlike antibiotics that destroy bacterial cell walls, azithromycin targets the protein-making machinery inside bacteria. It binds to a specific part of bacterial ribosomes called the 50S subunit, which is like the 'factory' where bacteria make the proteins they need to survive and multiply. By blocking this protein production, azithromycin essentially starves the bacteria of essential proteins, causing them to stop growing and eventually die. What makes azithromycin particularly special is its ability to concentrate in tissues at levels much higher than in the blood - it can reach concentrations in respiratory tissues that are 10-100 times higher than blood levels. This exceptional tissue penetration is why it works so well for lung, sinus, and ear infections. The medication also has a very long half-life, meaning it stays active in the body for days after the last dose is taken. This is why azithromycin courses are typically much shorter (3-5 days) compared to other antibiotics that need to be taken for 7-10 days. The drug continues working for several days after you stop giving it, maintaining therapeutic levels in infected tissues. Azithromycin is particularly effective against 'atypical' bacteria like Mycoplasma pneumoniae and Chlamydia pneumoniae, which are common causes of walking pneumonia in children and don't respond well to traditional antibiotics like amoxicillin. It also works against many typical respiratory bacteria while having excellent activity against some resistant strains that other antibiotics might miss.
-
-
Contributes to activity against some resistant organisms
Bioavailability
37-40% (moderate oral absorption)
Time to Peak
2-3 hours after oral dose
Food Effect
capsules: Food decreases absorption by 23%; tablets: Food has minimal effect; suspension: Food slightly decreases rate but not extent; clinical recommendation: Can be taken with or without food
Route
Not specified
Hepatic metabolism (minor role)
Half-life
terminal half life: 68-72 hours (very long); tissue half life: 2-4 days in most tissues; clinical significance: Allows once-daily dosing and short courses
Primary Route
Biliary excretion (60-70%)